Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial

Eskandary, F; Durr, M; Budde, K; Doberer, K; Reindl-Schwaighofer, R; Waiser, J; Wahrmann, M; Regele, H; Spittler, A; Lachmann, N; Firbas, C; Muhlbacher, J; Bond, G; Halloran, PF; Chong, E; Jilma, B; Bohmig, GA

Bohmig, GA (reprint author), Med Univ Vienna, Div Nephrol & Dialysis, Dept Med 3, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.; Jilma, B (reprint author), Med Univ Vienna, Dept Clin Pharmacol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.

TRIALS, 2019; 20 ():

Abstract

BackgroundLate antibody-mediated rejection (ABMR) triggered by donor-specific antibodies (DSA) is a cardinal cause of kidney allograft dysfunction and......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索